Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy InspireMD stock

Own InspireMD stock in just a few minutes.

InspireMD, Inc is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NYSE MKT and all prices are listed in US Dollars. InspireMD employs 45 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in InspireMD

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NSPR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

InspireMD share price

Use our graph to track the performance of NSPR stocks over time.

InspireMD shares at a glance

Information last updated 2021-04-23.
52-week range$0.28 - $1.48
50-day moving average $0.66
200-day moving average $0.57
Wall St. target price$1.05
PE ratio 0.5892
Dividend yield N/A (0%)
Earnings per share (TTM) $-9.91

Buy InspireMD shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy InspireMD stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is InspireMD under- or over-valued?

Valuing InspireMD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of InspireMD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

InspireMD's P/E ratio

InspireMD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, InspireMD shares trade at around 1x recent earnings.

InspireMD financials

Revenue TTM $2.5 million
Gross profit TTM $83,000
Return on assets TTM -44.97%
Return on equity TTM -120.19%
Profit margin 0%
Book value $0.25
Market capitalisation $53 million

TTM: trailing 12 months

Shorting InspireMD shares

There are currently 1.5 million InspireMD shares held short by investors – that's known as InspireMD's "short interest". This figure is 57.2% down from 3.6 million last month.

There are a few different ways that this level of interest in shorting InspireMD shares can be evaluated.

InspireMD's "short interest ratio" (SIR)

InspireMD's "short interest ratio" (SIR) is the quantity of InspireMD shares currently shorted divided by the average quantity of InspireMD shares traded daily (recently around 7.4 million). InspireMD's SIR currently stands at 0.21. In other words for every 100,000 InspireMD shares traded daily on the market, roughly 210 shares are currently held short.

However InspireMD's short interest can also be evaluated against the total number of InspireMD shares, or, against the total number of tradable InspireMD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InspireMD's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 InspireMD shares in existence, roughly 10 shares are currently held short) or 0.0135% of the tradable shares (for every 100,000 tradable InspireMD shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InspireMD.

Find out more about how you can short InspireMD stock.

InspireMD share dividends

We're not expecting InspireMD to pay a dividend over the next 12 months.

Have InspireMD's shares ever split?

InspireMD's shares were split on a 1:50 basis on 31 March 2019. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.

InspireMD share price volatility

Over the last 12 months, InspireMD's shares have ranged in value from as little as $0.282 up to $1.48. A popular way to gauge a stock's volatility is its "beta".

NSPR.US volatility(beta: 1.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while InspireMD's is 1.9906. This would suggest that InspireMD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

InspireMD overview

InspireMD, Inc. , a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site